Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023

BUY
$54.2 - $71.67 $357,611 - $472,878
6,598 New
6,598 $431,000
Q1 2023

May 15, 2023

BUY
$53.43 - $68.12 $433,210 - $552,316
8,108 Added 250.09%
11,350 $700,000
Q4 2022

Feb 14, 2023

BUY
$61.23 - $83.62 $198,507 - $271,096
3,242 New
3,242 $206,000
Q2 2022

Aug 15, 2022

SELL
$52.13 - $93.81 $4.1 Million - $7.37 Million
-78,600 Closed
0 $0
Q1 2022

May 13, 2022

BUY
$64.92 - $99.47 $5.1 Million - $7.82 Million
78,600 New
78,600 $7.12 Million
Q4 2021

Feb 14, 2022

SELL
$76.51 - $93.96 $2.83 Million - $3.47 Million
-36,972 Closed
0 $0
Q3 2021

Nov 15, 2021

BUY
$71.29 - $95.99 $1.9 Million - $2.56 Million
26,712 Added 260.35%
36,972 $3 Million
Q2 2021

Aug 16, 2021

BUY
$79.62 - $114.85 $621,195 - $896,059
7,802 Added 317.41%
10,260 $957,000
Q1 2021

May 18, 2021

BUY
$77.91 - $125.92 $191,502 - $309,511
2,458 New
2,458 $263,000

Others Institutions Holding NARI

About Inari Medical, Inc.


  • Ticker NARI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 53,389,700
  • Market Cap $2.2B
  • Description
  • Inari Medical, Inc., a medical device company, develops, manufactures, markets, and sells devices for the interventional treatment of venous diseases in the United States. The company provides ClotTriever, a mechanical thrombectomy system, which is designed to core, capture, and remove large clots from large vessels, as well as for treatment of ...
More about NARI
Track This Portfolio

Track Verition Fund Management LLC Portfolio

Follow Verition Fund Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Verition Fund Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Verition Fund Management LLC with notifications on news.